What Semacare does

Semacare (Shenzhen Semacare Medical Technology Co., Ltd / 深圳旭宏医疗科技有限公司) is a Shenzhen-headquartered medical technology company founded in January 2019 that builds AI-enabled cardiovascular monitoring hardware and companion software. Its flagship MetaCor™ product is a 10-gram, coin-sized, IP67-rated wearable ECG patch that captures medical-grade signals at 500Hz sampling for up to 48 hours of continuous wear, targeting patients with or at risk of cardiovascular disease, their families, and cardiologists who use the captured data for interpretation. A secondary line, HOMER™, combines a traditional nursing ID badge with a handheld clinical device intended for hospital staff workflows.

The company's proprietary MetaAI™ machine learning algorithm is trained on a corpus of more than ten million labeled clinical ECG records and is designed to recognize over 16 types of arrhythmia in real time, layered on a Glasgow-algorithm baseline that Semacare cites as the industry gold standard. The hardware-software stack pairs the MetaCor patch with two companion mobile applications — MetaHealth for patients and families and MetaBand for nursing staff — creating a connected data loop that links in-hospital monitoring (via HOMER) to at-home monitoring (via MetaCor). The company states it cooperates with research institutions across China, Australia, and the United States, although no peer-reviewed publication, algorithm patent, or medical-device regulatory clearance beyond an Internet Pharmaceutical Information Service Qualification Certificate (non-operational, certificate (粤)-非经营性-2020-0035) is documented in the input.

Commercially, Semacare is pre-revenue. MetaCor was announced as nearing market launch in 2020 after two years of development and is sold only via a website-based "Notify Me" pre-launch waitlist offering a complimentary voucher; pricing is not publicly disclosed. The intended revenue mix spans consumer hardware unit sales (MetaCor), B2B hospital hardware deployments (HOMER), potential subscription or premium services inside MetaHealth/MetaBand, and app-mediated professional services connecting patients to cardiologists. Distribution is entirely company-controlled (own website, app stores, direct enterprise sales), with no third-party resellers. The company has raised approximately $1.49 million in seed funding from ISVI (March 2019) and is led by co-founder and CEO Boyang Wang and co-founder and COO Roger Luo. Headcount is estimated below 50 employees based on an active hiring footprint of roughly ten open roles during 2019–2020 spanning sales, embedded hardware and software engineering, AI/algorithm research, and brand copywriting.

Name

Semacare

Legal name

SHENZHEN SEMACARE MEDICAL TECHNOLOGY CO., LTD

Website

https://semacare.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Semacare is a Shenzhen-based medical technology company developing AI-powered wearable ECG monitoring patches (MetaCor) and a nursing smart badge (HOMER) for continuous cardiac care, serving cardiovascular patients, families, cardiologists, and hospital nursing staff.

Ownership category

akta.pro rank

Product category

Wearable Cardiovascular Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

akta.pro secondary industries

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Cardiology Telemedicine Platforms (HLALAGAB), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• Wearable ECG monitoring
• Cardiac arrhythmia detection
• Medical AI algorithms
• Remote patient monitoring
• Connected cardiovascular devices

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. MetaCor Hardware Sales: Pre-revenue hardware product line: MetaCor is a wearable ECG patch intended for one-time/recurring device purchase via the company website; commercial launch pending at time of source capture. Stream type: hardware unit sales to consumers and potentially clinical partners.
2. HOMER Smart Badge Hardware Sales: B2B hardware product: HOMER is a smart badge for nursing staff inside hospitals, generating revenue through device unit sales or fleet deployment to healthcare institutions.
3. MetaHealth / MetaBand Companion Apps: Mobile applications for patients and families (MetaHealth) and nurses (MetaBand) enable ongoing engagement, data access, and a potential channel for subscription or premium services, including communication with cardiologists.
4. Cardiologist Professional Services: App-mediated professional services connecting patients with cardiologists for ECG reading and consultation, generating service-based revenue in addition to hardware sales.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Semacare designs, manufactures and sells connected cardiovascular monitoring hardware—the MetaCor™ wearable ECG patch and HOMER™ nursing smart badge—powered by its proprietary MetaAI™ machine-learning algorithm that recognizes 16 types of arrhythmia from continuous ECG data. The hardware is paired with companion mobile apps (MetaHealth for patients and families, MetaBand for nurses) and a cardiologist consultation channel that together deliver a hospital-to-home cardiac monitoring and early-detection platform.

Product overview

Semacare (Shenzhen Semacare Medical Technology Co., Ltd / 深圳旭宏医疗科技有限公司) operates a connected cardiovascular health platform that pairs AI-powered wearable hardware with companion mobile applications. The flagship wearable is the MetaCor™ ECG monitoring patch, a 10g IP67-rated coin-sized device that continuously captures ECG data and feeds it to the proprietary MetaAI™ machine learning algorithm (which also incorporates the Glasgow gold-standard algorithm) to detect 16 types of arrhythmia. The MetaHealth and MetaBand mobile apps bind to Semacare's health measurement devices, store users' physiological data in their personal data center, and enable communication with cardiologists. A separate line, HOMER™, is a smart badge that combines a traditional ID badge with a nursing handheld terminal for clinical staff.

Differentiator

Problem solved

Functional benefit

Brands

• MetaCor™: Ultra-thin wireless ECG monitoring electrode patch that integrates with the MetaHealth/MetaBand app to enable remote cardiologist communication; 10g, coin-sized, IP67, up to 48 hours continuous monitoring, arrhythmia detection.
• HOMER™
• MetaAI™
• MetaHealth
• MetaBand

Products and services

• MetaCor™ ECG Monitoring Patch Ultra-thin, coin-sized (10g) wireless ECG electrode patch with IP67 splash/water/dust resistance, 40% stretchable electrodes, and up to 48 hours of continuous single-charge ECG monitoring. Pairs with the MetaHealth app so users can communicate with cardiologists and receive streamlined monitoring for chronic cardiovascular conditions.
• HOMER™ Smart Badge Smart personal digital assistant that integrates a traditional hospital ID badge with a nursing handheld terminal, designed for clinical staff workflows and to pair with the MetaBand nurse app for in-hospital patient monitoring.
• MetaHealth Mobile Application Mobile app that pairs with Semacare health measurement devices to measure and record users' physiological data, bind devices to the user's account, upload data to the personal data center, and enable communication with cardiologists.
• MetaBand Mobile Application Mobile app that pairs with Semacare health measurement devices for measuring and recording health data, binding the device to the user's account, and storing data in the user's data center.

Quantifiable outcome

• 10M+ labeled clinical ECG samples in the MetaAI™ training dataset
• +6 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature12 records

Scale indicators7 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• iRhythm Technologies: US-listed maker of the Zio long-duration wearable ECG patch and AI arrhythmia-detection platform — the closest direct analogue to MetaCor™ + MetaAI™ in terms of form factor, multi-day continuous monitoring, and ML-driven arrhythmia classification targeting both patients and cardiologists.
• AliveCor: Sells the KardiaMobile consumer/single-lead ECG device plus an AI arrhythmia-detection app — directly comparable to Semacare's MetaCor™ hardware + MetaHealth app + AI ECG-reading-aid combination, particularly in the consumer-cardiology crossover use case.
• Preventice Solutions (Boston Scientific): Provider of wearable cardiac monitoring patches and AI-assisted ECG reporting services for hospitals and clinics — a direct competitor in the ambulatory ECG monitoring and AI-ECG interpretation category Semacare targets with MetaCor™ and MetaAI™.

Broad incumbents

• Apple (Apple Watch ECG): Apple Watch offers FDA-cleared single-lead ECG and AFib detection on the wrist — a broad incumbent whose consumer ECG feature set overlaps MetaCor™'s at-home arrhythmia-screening use case, while competing on distribution, brand, and recurring ecosystem lock-in that Semacare cannot match.
• Philips (Cardiac Monitoring / BioTelemetry): Philips (including its BioTelemetry extended Holter/MCOT business) is a global incumbent in ambulatory cardiac monitoring and ECG-reading services, offering overlapping capabilities with MetaCor™ + MetaAI™ as part of a broader cardiology portfolio rather than as a wearable-only specialist.
• GE Healthcare (Patient Monitoring): Global incumbent in hospital patient monitoring and ECG telemetry infrastructure — a broad incumbent whose hospital-side telemetry offering is the institutional counterpart to Semacare's HOMER™ smart-badge / hospital workflow play.

Emerging players

• Biotricity: Developer of wearable cardiac monitoring devices (e.g., Bioflux) with remote patient monitoring and AI-assisted arrhythmia analytics — a smaller-scale emerging peer in the same wearable-ECG + RPM category Semacare addresses with MetaCor™ and HOMER™.
• Vivalink: Provider of remote cardiac monitoring patches and RPM platform for hospitals and clinics — an emerging peer with comparable wearable ECG form factor and continuous-monitoring + cloud analytics model overlapping MetaCor™.

Regional players

• Huami / Zepp Health (Amazfit): China-headquartered consumer wearables maker whose Amazfit and Zepp devices increasingly incorporate ECG/heart-health features — a regional peer operating out of the same home market with broader consumer-electronics distribution and stronger consumer-brand reach than Semacare.
• Shenzhen Mindray Bio-Medical Electronics: Major China-based medical-device maker with patient-monitoring and ECG product lines sold into hospitals domestically and globally — a regional incumbent that competes with Semacare's HOMER™ hospital-channel and MetaCor™ clinical aspirations within China and emerging markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Semacare